Greening the pharmaceutical supply chain
Article
Belal, M.M., Shukla, V. and Balasubramanian, S. 2024. Greening the pharmaceutical supply chain. Business Strategy and the Environment. https://doi.org/10.1002/bse.4077
Type | Article |
---|---|
Title | Greening the pharmaceutical supply chain |
Authors | Belal, M.M., Shukla, V. and Balasubramanian, S. |
Abstract | The pharmaceutical sector is critical from a life-saving perspective. However, it also poses significant environmental challenges due to large consumptions of non-renewable materials and energy, as also extensive by-product and waste generation. Addressing these issues is paramount, though surprisingly, research on it has largely been theoretical, fragmented and incomplete. These shortcomings are sought to be addressed in this work where a comprehensive green supply chain management (GSCM) framework for the sector is first developed through a systematic literature review. It is then empirically assessed and validated for UK's pharmaceutical sector through 47 interviews and analyses of 112 corporate environmental reports that covered all key stakeholders. Innovative and Bio-pharma players were found to be at the forefront of the greening efforts with generic players lagging behind. High levels of solvent recycling, AI-based drug design, and emphasis on Ecopharmacovigilance were observed for the Innovative players. The key drivers for greening were found to be regulatory pressures (e.g., f-gas, ERA, IED) and cost saving potential, with their influence being particularly greater for the Innovative players. Similarly, complex marketing authorization process, high investment requirements, lack of green culture and time pressure were revealed as the key barriers to greening. On the downstream side, lack of environment-related regulatory guidance on prescribing and contradictory regulatory guidance on disposing unused/expired drugs were identified as factors having a significant impact on the environmental loading of drugs. Overall, the study findings can help assess the green readiness of the sector, as also develop stakeholder-specific policy interventions and support mechanisms to increase green adoption. |
Keywords | barriers; drivers; green practices; green supply chain management; performance; pharmaceuticals |
Sustainable Development Goals | 12 Responsible consumption and production |
Middlesex University Theme | Sustainability |
Publisher | Wiley |
Journal | Business Strategy and the Environment |
ISSN | 0964-4733 |
Electronic | 1099-0836 |
Publication dates | |
Online | 09 Dec 2024 |
Publication process dates | |
Submitted | 24 Feb 2024 |
Accepted | 13 Nov 2024 |
Deposited | 03 Jan 2025 |
Output status | Published |
Publisher's version | License File Access Level Open |
Copyright Statement | This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
Digital Object Identifier (DOI) | https://doi.org/10.1002/bse.4077 |
Web of Science identifier | WOS:001373959800001 |
Language | English |
https://repository.mdx.ac.uk/item/1xw6y2
Download files
Publisher's version
Bus Strat Env - 2024 - Belal - Greening the Pharmaceutical Supply Chain.pdf | ||
License: CC BY 4.0 | ||
File access level: Open |
18
total views8
total downloads18
views this month8
downloads this month